Efficacy Study of Recombinant Protein (Ecallantide) to Reduce Blood Loss During Primary Coronary Bypass Grafting or Valve Repair/Replacement
about
Efficacy Study of Recombinant Protein (Ecallantide) to Reduce Blood Loss During Primary Coronary Bypass Grafting or Valve Repair/Replacement
description
clinical trial
@en
klinisch onderzoek
@nl
name
Efficacy Study of Recombinant ...... ng or Valve Repair/Replacement
@en
type
label
Efficacy Study of Recombinant ...... ng or Valve Repair/Replacement
@en
prefLabel
Efficacy Study of Recombinant ...... ng or Valve Repair/Replacement
@en
P6153
P1476
KALAHARI-1: Kallikrein Antagon ...... equiring Institution of Bypass
@en
P3098
NCT00448864
P580
2007-05-01T00:00:00Z
P582
2008-07-01T00:00:00Z